-+ 0.00%
-+ 0.00%
-+ 0.00%

Needham Maintains Buy on Veradermics, Raises Price Target to $164

Benzinga·07/15/2026 17:10:26
Listen to the news
Needham analyst Serge Belanger maintains Veradermics (NYSE:MANE) with a Buy and raises the price target from $136 to $164.